Cancer Research

Fluorescence Imaging for Tracking Cellular Processes
Tech & Innovation Fluorescence Imaging for Tracking Cellular Processes

In the fast-evolving field of cellular biology, fluorescence imaging has emerged as a revolutionary tool for tracking cellular processes. With its ability to provide detailed and dynamic views of life on a microscopic scale, it has opened new paths for research and understanding, profoundly

Kivu Biosciences Raises $92M to Develop Precision Cancer Treatments
Research & Development Kivu Biosciences Raises $92M to Develop Precision Cancer Treatments

Kivu Biosciences, a San Francisco-based biotechnology startup, has made headlines by raising an impressive $92 million in its Series A funding round. This influx of investment will significantly bolster the company's efforts to advance its groundbreaking antibody-drug conjugates (ADCs), which hold

FDA Approves First Targeted Therapy for Advanced Gastric Cancer
Research & Development FDA Approves First Targeted Therapy for Advanced Gastric Cancer

In a significant leap forward for oncology, the U.S. Food and Drug Administration (FDA) has given the green light to Astellas Pharma Inc.'s VYLOY (zolbetuximab-clzb) for treating adults with advanced, unresectable, or metastatic human epidermal growth factor receptor 2 (HER2)-negative gastric or

Gilead Pulls Trodelvy for Bladder Cancer After Failed Clinical Trial
Research & Development Gilead Pulls Trodelvy for Bladder Cancer After Failed Clinical Trial

Gilead Sciences recently announced its decision to withdraw Trodelvy from the market as a treatment for bladder cancer, following disappointing results from its confirmatory TROPiCS-04 clinical trial. This marks a notable shift for a drug that initially showed promise in shrinking tumors and

Can Novartis and Baiyu Revolutionize Cancer Treatment Together?
Research & Development Can Novartis and Baiyu Revolutionize Cancer Treatment Together?

In a bold move that underscores its commitment to advancing cancer therapies, Novartis has taken a significant step by investing $70 million upfront in Chengdu Baiyu Pharmaceutical for global rights to a small molecule cancer treatment. This partnership is accompanied by potential milestone

Boehringer and Circle Partner on Precision Cancer Therapy Innovation
Research & Development Boehringer and Circle Partner on Precision Cancer Therapy Innovation

In an ambitious endeavor to revolutionize cancer treatment, Boehringer Ingelheim and Circle Pharma have entered into a research partnership and license agreement aimed at developing a first-in-class cyclin inhibitor. This groundbreaking collaboration is set to provide novel treatment options for

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later